← Open Payments lookup

ALYSSA ROSALES: Open Payments

NPI 1376203406 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$343 in 16 payments from 8 companies in 2025. Trend: 2023 $522 · 2024 $543 · 2025 $343

Food & beverage: $343
CompanyPaymentsAmount
Novo Nordisk Inc5$118
Otsuka America Pharmaceutical, Inc.4$93
Lilly USA, LLC2$38
PFIZER INC.1$24
Sumitomo Pharma America, Inc.1$19
GlaxoSmithKline, LLC.1$19
AstraZeneca Pharmaceuticals LP1$17
Merck Sharp & Dohme LLC1$15

Products named: REXULTI, Wegovy, MOUNJARO, Rybelsus, ELIQUIS, Ozempic, GEMTESA, SHINGRIX.

Industry payments across TX — which companies pay providers there.